Table of Contents

  1. Introduction to Voice of Healthcare (VOH)
  2. Brief on the National IVF Summit held on 22nd June 2025
  3. Event Glimpses
  4. Opening Remarks from the IVF Summit
  5. Recommendations/Feedback from Expert Panel Discussions
  6. Panel 1: Women's Health in Transition: Ethics, Empowerment & Ecosystems
  7. Panel 2: Laws of Life – ART, Access & Autonomy
  8. Panel 3: The Fertility Divide – Breaking Economic Barriers
  9. Panel 4: Tomorrow's Baby – Technology, Ethics & Identity
  10. Panel 5: The Unspoken Journey – Male Fertility & Emotional Wellbeing
  11. Panel 6: Fertility Inc. – India's Next Healthcare Unicorn?
  12. Presentation: Prenatal Screening in IVF – Ensuring a Healthy Start
  13. Partner Spotlight: Digital Transformation in IVF Labs
  14. Fireside Chats - Female leaders in Fertility & the Future They're Shaping
  15. Summit Summary & Key Takeaways
  16. IVF Excellence & Innovation Awards
  17. Winners List

Introduction to Voice of Healthcare (VOH)

Voice of Healthcare (VOH Network) is a healthcare industry focussed platform dedicated to catalysing transformation in the Indian healthcare ecosystem. Conceived as a collaborative bridge between stakeholders, VOH brings together healthcare leaders, policy experts, clinicians, technologists, and innovators to co-create sustainable and inclusive models of care.

Through national summits, virtual exchanges, knowledge reports, and stakeholder engagement campaigns, VOH champions initiatives that advance patient-centricity, ethical practice, technological innovation, and policy reform across healthcare verticals—including reproductive medicine and fertility care.

Mission

To make healthcare a national priority by uniting voices from across the healthcare spectrum—clinicians, institutions, policymakers, and industry leaders—to drive meaningful and measurable transformation. VOH empowers stakeholders to co-create growth journeys, shape policy dialogue, and build resilient healthcare systems that serve every citizen.

Vision

To inspire, enable, and empower every spoke and stakeholder in the healthcare wheel by creating a multi-stakeholder ecosystem. VOH envisions a healthcare landscape where innovation, equity, and collaboration converge to ensure access, quality, and dignity for all.

List of Abbreviations

Abbreviation Full Form
IVFIn Vitro Fertilization
ARTAssisted Reproductive Technology
IFSIndian Fertility Society
ISARIndian Society for Assisted Reproduction
FOGSIFederation of Obstetric and Gynaecological Societies of India
PCOSPolycystic Ovary Syndrome
AMHAnti-Müllerian Hormone
TFRTotal Fertility Rate
ICMRIndian Council of Medical Research
PRPPlatelet-Rich Plasma
PGTPreimplantation Genetic Testing
AIArtificial Intelligence
ICSIIntracytoplasmic Sperm Injection
DNADeoxyribonucleic Acid
NPSNet Promoter Score
IRDAInsurance Regulatory and Development Authority (of India)

Brief on the National IVF Summit & Awards 2025

Date: 22nd June 2025

Venue: Courtyard by Marriott, Mumbai

Recognizing the urgent need to address the evolving landscape of fertility care in India, Voice of Healthcare (VOH), in collaboration with the Indian Fertility Society (IFS), convened the 2nd Edition of the National IVF Summit & Awards 2025—a flagship event designed to bring together policy architects, clinical leaders, technologists, and patient advocates on a unified platform.

Theme: "Ethics | Access | Innovation"

Ethics

In the post-ART Act era, the summit emphasized the importance of upholding ethical frameworks in assisted reproductive technologies. Discussions explored how clinicians and institutions can align with national guidelines while preserving patient autonomy, informed consent, transparency in outcomes, and the psychological well-being of all stakeholders—including donors, surrogates, and intended parents.

Access

Fertility care in India is still largely confined to urban centers and elite segments. The summit addressed the urgent need to decentralize IVF services and make them equitable and affordable for couples in Tier 2, Tier 3 cities, and underserved regions. Experts discussed cost-effective models, insurance integration, and public-private collaborations to bridge these economic and geographic divides.

Innovation

The conference spotlighted cutting-edge advancements transforming fertility science—from AI-powered embryo selection and personalized stimulation protocols to next-gen lab infrastructure and tele-IVF platforms. Emphasis was placed on responsibly integrating emerging technologies to enhance outcomes, efficiency, and patient experiences across the fertility journey.

Designed as a high-impact policy forum and clinical exchange, the summit hosted:

  • 6 multi-perspective expert panels
  • 2 partner led spotlight presentations
  • A powerful fireside chat
  • The prestigious IVF Excellence & Innovation Awards Recognizing individuals and institutions leading change in reproductive healthcare

The summit reaffirmed VOH's commitment to building a resilient, inclusive and future forward fertility care ecosystem in India - where science and empathy meet, and every journey to parenthood is supported with dignity, safety & hope.

Objective of the National IVF Summit 2025

The 2nd Edition of the National IVF Summit & Awards 2025, organized by Voice of Healthcare (VOH) in partnership with the Indian Fertility Society (IFS), was designed as a collaborative, policy-shaping platform to address the emerging priorities and persistent challenges within India's fertility landscape.

The key objectives were to:

Bridge Policy and Practice

Convene regulators, clinicians, technologists, and industry leaders to align ART implementation with ethical, equitable, and accessible care.

Advance Clinical and Technological Innovation

Explore and promote responsible adoption of new technologies like AI-powered embryo selection, tele-IVF, and preventive diagnostics.

Strengthen Ethical and Inclusive Fertility Care

Re-examine laws and frameworks such as the ART Act and surrogacy regulations to ensure they support diverse family structures, informed consent, and reproductive autonomy.

Enable Access and Affordability

Discuss public-private partnerships, insurance models, and hub-and-spoke systems to bring fertility care closer to underserved regions.

Recognize Leadership and Inspire Change

Celebrate excellence and innovation in IVF through awards and spotlight sessions, fostering a culture of quality and patient-first thinking.

Promote Gendered and Holistic Approaches

Focus on women's and men's fertility journeys, hormonal health, emotional well-being, and the evolving identity of parenthood in modern India.

Event Glimpses

Capturing the moments of excellence, collaboration, and innovation from the National IVF Summit & Awards 2025. These glimpses showcase the prestigious award ceremonies, expert panel discussions, and the coming together of industry leaders who are shaping the future of fertility care in India.

IVF Summit 2025 Event Collage

Moments from the National IVF Summit & Awards 2025 - Panel discussions, award ceremonies, and networking sessions

The summit brought together distinguished healthcare professionals, policy makers, and industry leaders, fostering meaningful discussions and recognizing outstanding contributions to the field of reproductive medicine.

Opening Remarks from the IVF Summit

Dr. Naveen Nishchal, Founding Chairman of Voice of Healthcare, opened the 2nd Edition of the National IVF Summit & Awards 2025 with a warm welcome to a distinguished audience that included stalwarts such as Dr. Pankaj Talwar, Dr. Shweta Mittal, Dr. Duru Shah, Dr. K.D. Nayar, Dr. Gouri Devi, and other eminent IVF specialists, embryologists, innovators, policymakers, students, and digital attendees joining through VOH's online platforms.

Dual Perspective on Fertility Ecosystem

In his address, Dr. Nishchal emphasized the dual lens through which he views the fertility ecosystem—as both a physician and an entrepreneur. He highlighted the positive trajectory of the IVF industry, citing consistent 15–18% CAGR growth, a market valuation nearing $1 billion, and the year-on-year expansion of fertility centers, clinicians, embryologists, and technologies contributing to India's growing IVF footprint.

Addressing Critical Challenges

However, he also cautioned against the less optimistic realities—notably the rising burden of infertility, which he attributed to factors like sedentary lifestyles, poor nutrition, pollution, and stress. More importantly, he underscored the critical gaps in access, affordability, and quality of fertility care across India's vast geography, pointing out that many towns and districts still lack a single IVF facility.

Call for Preventive Awareness

Dr. Nishchal passionately advocated for preventive awareness, especially around timely parenthood, and called on the community to collectively address these challenges. He stressed that the summit exists not just as a celebratory platform, but as a purpose-driven convergence of doctors, embryologists, innovators, regulators, and clinicians—committed to redefining the future of fertility care in India.

Vision for the Future

He concluded with optimism and enthusiasm for the day ahead, promising thought-provoking discussions, multi-perspective panels, and a grand celebration honoring IVF leaders and change-makers at the awards ceremony.

Recommendations from the Opening Address

Based on the keynote remarks by Dr. Naveen Nishchal, the following key recommendations were outlined:

🌐

Improve Access

Expand IVF services to underserved regions and districts across India.

💰

Enhance Affordability

Explore financial models and insurance coverage to make fertility care more accessible.

⚖️

Promote Ethical Innovation

Balance technological advancement with adherence to ethical standards and transparency.

📢

Raise Awareness

Encourage timely parenthood and fertility literacy among young couples through public education.

👨‍⚕️

Support Workforce Development

Strengthen training for IVF professionals and standardize clinical practices.

🤝

Foster Collaboration

Bring together doctors, embryologists, innovators, and policymakers to co-create the future of fertility care.

"This summit matters. It brings together every stakeholder to make fertility care in India more accessible, affordable, and high-quality. Let us shape the future—together."

— Dr. Naveen Nishchal

Panel 1: Women's Health in Transition – Advancing Fertility, Hormonal Health & Holistic Well-Being

Distinguished Panel Members

Dr. Shweta Mittal Gupta

Secretary General, Indian Fertility Society (IFS)

Dr. (Prof.) Col. Pankaj Talwar

President, Indian Fertility Society (IFS)

Dr. Amit Patki

President, Indian Society for Assisted Reproduction (ISAR)

Dr. Anushree Patil

Scientist, Indian Council of Medical Research (ICMR)

Dr. Duru Shah

Founder, PCOS Society of India
Past President, FOGSI

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Shweta Mittal Gupta
  • 1 in 6 couples in India experience infertility.
  • Diagnostics have evolved from conventional hormone tests to sensitive AMH and genetic polymorphism analysis, allowing faster and more targeted interventions.
  • Standardize AMH and polymorphism screening in early fertility assessments.
  • Educate both clinicians and patients on interpreting diagnostic data to support informed choices.
  • Diagnostics shape patient journeys—precision testing enables early action.
  • Empowered patients make confident, informed decisions.
Dr. (Prof.) Col. Pankaj Talwar
  • India has over 3,000 towns and 700+ districts, but only ~1,200 cities have IVF centres.
  • ART contributes to 2.5–3% of all national deliveries and is growing at a CAGR of 15–18%.
  • IVF practices must also become environmentally sustainable ("Green IVF").
  • Expand ART services to Tier 3 and 4 cities through trained gynaecologists.
  • Promote "Green IVF" protocols that reduce carbon footprints of clinics.
  • IVF expansion must be inclusive and ecologically responsible.
  • Rural India cannot be left out of the fertility care equation.
Dr. Amit Patki
  • IVF success should go beyond conception and track maternal and neonatal outcomes.
  • Less than 2% of IVF centres currently share data nationally, hindering quality benchmarking and policy evolution.
  • Integrate fertility data into Ayushman Bharat Digital Health IDs for continuity of care.
  • Define success metrics beyond live birth rates to include baby health and maternal well-being.
  • IVF credibility depends on transparency and long-term outcomes.
  • Digital integration is vital for national monitoring and patient trust.
Dr. Anushree Patil
  • PCOS affects 16% of Indian women; 1 in 5 under the age of 25 shows signs of PCOS.
  • Declining urban TFR (<2.0) often misleads policymakers into assuming biological infertility—when it's often social or lifestyle-driven.
  • Establish district-level, multidisciplinary PCOS and infertility clinics.
  • Use ICMR/NFHS data to shape localized fertility programs and separate social from biological factors.
  • PCOS is not just a reproductive issue—it is metabolic and systemic.
  • Policy must distinguish between sociocultural delays and clinical infertility.
Dr. Duru Shah
  • Myths around PCOS lead to delayed diagnoses and unnecessary IVF referrals.
  • Preconception hormone balance directly impacts foetal health via epigenetic changes.
  • Few insurance schemes currently cover PCOS screening or early hormonal therapy.
  • Implement hormonal health education in schools and colleges.
  • Include PCOS care in national insurance policies and amplify public campaigns like Vijaya.
  • Pre-IVF hormonal correction may prevent IVF in many cases.
  • Preconception health influences generational health outcomes.

Quotes from Panelists

Dr. Shweta Mittal Gupta

"We used to take the whole day to get AMH results. Today, I get it in one and a half hours. But it's not just about speed—it's about validated machines, improved efficacy, and giving patients choices to take valid decisions."

"So many advancements have happened... we are trying to make our whole process of fertility care way better."

Dr. (Prof.) Col. Pankaj Talwar

"We have barely 8 tier-one cities in the country where fertility services are well developed. The rest of India is still underserved Tier 3 and 4 cities are not very well defined and mostly lack proper ART services."

Dr. Amit Patki

"We go to international conferences and feel ashamed that such a big country has no unified data to share. Everyone is doing excellent work, but documentation is lacking."

"It’s time to come together—IFS, ISAR, FOXY—to build a data registry so India can be recognized as a global leader in IVF."

Dr. Anushree Patil

"There is a difference between low Total Fertility Rate (TFR) and biological infertility. TFR can decline for sociocultural reasons, not necessarily due to clinical infertility."

"We don’t have national-level ICMR data on infertility, but we do have NFHS estimates based on five-year inability to conceive."

Dr. Duru Shah

"We have to look at PCOS differently—not just as an infertility condition. Many women need hormonal correction, not IVF."

"We must treat women before conception, because epigenetics tells us that fetal outcomes are affected by the mother’s hormonal status."

Panel 2: Laws of Life - ART, Access & Autonomy

Distinguished Panel Members

Dr. K.D. Nayar

Chief Consultant, Akanksha IVF Centre

Past President, Indian Fertility Society (IFS)

Dr. M. Gouri Devi

Director, Department of Reproductive Medicine, Ridge IVF

Vice President, Fertility Preservation Society of India

Mr. Divyanshu Priyam

Partner, Lex Curium

Mr. Manu Varticus

Managing Partner, Varticus Partners (Moderator)

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. K.D. Nayar
  • ART Act restricts age to 23–50 (women) and up to 55 (men); does not reflect India’s early marriage patterns or reproductive choices.
  • One-donor-per-couple rule is impractical with a 35–40% IVF success rate.
  • Excludes single men and LGBTQ+ individuals.
  • Expand eligibility to single parents and same-sex couples.
  • Permit repeat donation based on live birth limit.
  • Simplify reporting formats for small IVF clinics.
  • India needs a rights-based ART law reflecting ground realities.
  • Legal flexibility ensures both access and quality care.
  • One-size-fits-all regulation risks excluding many deserving families.
Dr. M. Gouri Devi
  • Altruistic-only surrogacy has become exploitative—surrogates earn nothing while intermediaries’ profit; overall costs have doubled (₹10–20 lakhs).
  • Consent remains ineffective in rural areas due to literacy and language barriers.
  • Introduce ethical, structured compensation for surrogates.
  • Translate consent documents into regional languages with counsellor involvement.
  • Define legal protocols for posthumous reproduction and gamete custody.
  • Surrogacy law must balance ethics with economic justice.
  • Rural women’s rights need safeguarding via localized education and consent.
  • Uniform interpretation is critical to avoid unintended exploitation.
Mr. Divyanshu Priyam
  • ART law implementation varies district vs. state-level authority.
  • No national donor tracking system; risk of excessive anonymous donations.
  • Judiciary is actively shaping rights (e.g., maternity benefits for surrogate mothers upheld in court).
  • Establish Aadhaar-linked ART and donor registries.
  • Standardize ART authority structures across states.
  • Encourage ongoing judicial–medical dialogue for real-time legal reform.
  • Regulatory infrastructure must evolve with science and lived experience.
  • Centralization ensures ethical enforcement and national data integrity.
  • Judiciary plays a vital role in protecting reproductive rights.

Quotes from Panelists

Dr. K.D. Nayar

"The problem with the law is that it’s made for urban, elite people—85% of our population is rural. We should have had more representation before framing this."

Dr. M. Gouri Devi

"Altruistic surrogacy has become a joke. The surrogate is not getting anything, but the agent gets paid, and costs have doubled."

Mr. Divyanshu Priyam

"The judiciary has played a huge role—granting maternity benefits to surrogate mothers, for instance. Law and society must move forward together."

Panel 3: The Fertility Divide – Breaking Economic Barriers

Distinguished Panel Members

Dr. Rohan Palshetkar

Unit Head, Bloom IVF

Professor, Dr. D.Y. Patil Medical College

Dr. Gunjan Gupta Govil

Co-founder & Director, Gunjan IVF World

Dr. Mohan Raizada

Director, Reproductive Immunology Center

Clinical Reproductive Immunologist

Mr. Vikas Anand

CEO & Co-founder, SAFETY Insurance

Dr. Navina Singh

Center Head & Senior Consultant, Birla Fertility & IVF, Mumbai

Chapter Secretary (Greater Mumbai), Indian Fertility Society (IFS)

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Rohan Palshetkar
  • IVF costs ₹1–3 lakhs/cycle (excluding meds, travel).
  • India lacks government subsidies like Belgium or Israel.
  • Insurance and financing access is near-zero.
  • Public–private partnership models with capped co-pay.
  • Rationalize use of ICSI and freeze-all protocols.
  • Engage policymakers to recognize IVF as essential care.
  • IVF affordability requires both clinical efficiency and financial innovation.
  • Policy support is essential for scaling access.
Dr. Mohan Raizada
  • High cost of failed IVF cycles rarely addressed.
  • Reproductive immunology can prevent repeat failures but is underutilized.
  • Introduce testing for immune-related implantation failure in selected cases.
  • Build awareness among clinicians about immunological causes of IVF failure.
  • Personalized care reduces long-term cost burden.
  • Preventive diagnostics = more success, fewer cycles.
Mr. Vikas Anand
  • IVF is not mandated under insurance laws in India.
  • Barriers: lifestyle perception, pricing unpredictability, lack of actuarial data.
  • IRDA should mandate basic IVF coverage.
  • Build a national fertility registry to guide actuarial pricing.
  • Pilot clinic-insurer partnerships with bundled cost models.
  • IVF insurance needs systemic reform, not isolated schemes.
  • Real-time clinical data is key to insurance innovation.
Dr. Gunjan Gupta Govil
  • Tier 2/3 regions have highest demand but lowest access.
  • IVF cost includes travel, wage loss, stay—rarely acknowledged in urban policy.
  • Implement hub-and-spoke clinics with centralized SOPs.
  • Use AI algorithms for optimized drug protocols.- Invest in education at school, college, and corporate levels.
  • Outreach must be rural-ready and digitally enabled.
  • Awareness and affordability must go hand in hand.

Quotes from Panelists

Dr. Rohan Palshetkarr

"When we do look at it, the biggest barrier is the high cost—and it's out of pocket. IVF can cost anywhere between ₹1 lakh to ₹3 lakhs per cycle, excluding drugs, stay, and travel. The lack of public funding and insurance makes it worse."

Dr. Mohan Raizada

"Rather than just reducing the cost of IVF, if we reduce the cost of failure, then we will definitely help these patients—both in saving money and achieving their goal of having a baby."

Mr. Vikas Anand

"The fertility divide exists because insurance still treats infertility as elective. But in 20 U.S. states, IVF is mandated under insurance—and those states see 3x the number of IVF cycles and clinics. That tells us everything."

Dr. Gunjan Gupta Govil

"The best model for affordable IVF is the hub-and-spoke system—especially for Tier 2 and Tier 3 cities. With digital tools and SOPs, we can bring quality care closer to patients while cutting down travel and wage loss."

Dr. Navina Singh (Moderator)

"Financing fertility isn’t just about cost—it is about access, agency, and justice."

Panel 4: Tomorrow’s Baby – Technology, Ethics & Identity

Distinguished Panel Members

Dr. Rishma Dhillon Pai

President-Elect, International Federation of Fertility Societies

Former President, ISAR and FOGSI

Dr. Suvarna Khadilkar

Professor & Head, Department of OBGYN

Bombay Hospital Institute of Medical Sciences

Secretary General, FOGSI (2025–2027)

Dr. Ritu Hinduja

Clinical Director, Cloudnine Fertility, Mumbai

Dr Balasaheb Khadbade

Chairman, Yashoda IVF & Director, Yashoda Postgraduate Institute of OBS-GYN

Dr. Kuldeep Jain

Director, KJ IVF & Laparoscopy Centre

Founder Secretary & Past President, Indian Fertility Society (IFS)

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Rohan Palshetkar
  • ART Act permits single women (21+) to pursue parenthood via ART or surrogacy.
  • India’s donor anonymity policy prevents future identity claims but also limits transparency.
  • Social acceptance of children born to single mothers remains limited.
  • Supplement legal rights with child-centric support and societal education.
  • Develop policies around long-term rights and psychosocial well-being of ART-born children.
  • Legal permission doesn’t ensure societal readiness.
  • Ethical practice must consider long-term impact on the child.
Dr. Suvarna Khadilkar
  • Stem cell fertility therapy is still experimental and not approved for clinical use in India.
  • Egg freezing is an underused but safe and legal option.
  • Clinicians often lack structured guidance on ART ethics.
  • Promote egg freezing as a preventive reproductive health service.
  • Create training programs on ART law and ethical boundaries.
  • Current technologies like egg freezing should be maximally utilized.
  • Ethics and legal literacy must be integral to ART practice.
Dr. Ritu Hinduja
  • Ovarian aging is increasing due to environmental stressors (e.g., pollution, microplastics).
  • PRP and stem cell treatments are unregulated and prematurely adopted.
  • Elective egg freezing remains the most viable tool for fertility preservationd.
  • Raise awareness about ovarian reserve decline and egg freezing timelines.
  • Avoid offering experimental treatments until approved.
  • Preventive fertility care must be prioritized over futuristic hype.
  • Clinical safety should guide every decision.
Dr Balasaheb Khadbade
  • Patients have started requesting aesthetic traits like blue eyes from donors.
  • PGT screens for 200+ diseases but is sometimes misinterpreted for enhancements.
  • Clinicians are pressured to fulfill ethically gray requests.
  • Limit PGT use to genuine medical indications.
  • Strengthen clinic-level ethics protocols and patient counseling.
  • Doctors must refuse ethically or legally inappropriate demands.
  • Clear ethical boundaries protect both child and clinician.
Dr. Kuldeep Jain(Moderator)
  • ART Act restricts gene editing to disease prevention, adopting a cautious stance.
  • Clinicians must balance innovation with ethical, legal, and societal responsibility.
  • Engage clinicians in shaping future ART policy.
  • Integrate ethics into clinical training and patient communication.
  • Science must be guided by law and conscience.
  • Future children’s dignity should lead every fertility decision.

Quotes from Panelists

Dr. Rishma Dhillon Pai

"The law gives me the right to become a parent. But is the child ready to be accepted by society? That’s the ethical dilemma."

Dr. Subarna Khadilkar

"Whatever technology we have today, put it to use fully—and of course, the research will one day be available to us in practical use."

Dr. Ritu Hinduja

"Why would a woman need stem cells in the future if today she has frozen her eggs?."

Dr Balasaheb Khadbade

"We have to fulfill patient expectations—but within the limits of the ART law and medical ethics."

Dr. Kuldeep Jain (Moderator)

"We cannot stop science. But we must ground our practice in reality, legality, and the best interest of the future child."

Panel 5: The Unspoken Journey: Male Fertility & Emotional Wellbeing

Distinguished Panel Members

Dr. Poonam Nayar

Consultant Clinical Psychologist, Mata Chanan Devi Hospital, New Delhi

Infertility Counselor, Akanksha IVF Centre

Dr. Vasundara Jagannathan

Founder & Medical Director, Sri Chakra Fertility

Dr. Sutapa Samanta

Senior IVF Specialist, Crysta IVF, Kolkata

Vakil Jagveer Singh

Clinical Application Manager, CooperSurgical India

Moderator: Dr. Kaustubh Kulkarni

Founder & Director, Siddhilife Assisted Reproduction Centre, Mumbai

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Vasundara Jagannathan
  • Male factor often skipped in initial fertility evaluation, especially in Tier 2/3 cities.
  • IVF centers are predominantly gynecology-led; many clinicians defer male evaluation.
  • Train gynecologists to perform preliminary male assessment.
  • Standardize male fertility screening protocols even in non-urban centers.
  • Male infertility must not be outsourced—it’s part of the core fertility diagnosis.
  • Clinical confidence in male reproductive evaluation is essential to timely treatment.
Dr. Sutapa Samanta
  • Sperm structure is integral to fertilization: head (genetic material), neck (mitochondria), tail (mobility).
  • Poor morphology may hinder fertilization even with ICSI.
  • Make structural sperm assessment (morphology, motility) routine.
  • Sensitize clinicians to functional sperm biology.
  • High sperm count ≠ high fertility—structure matters.
  • Clinician awareness can improve ICSI outcomes and reduce cycle failures.
Vakil Jagveer Singh
  • Semen analysis is under-standardized across India.
  • Cited WHO 2010 and 2020 as gold standards; many labs don’t follow them. - DNA fragmentation testing often overused or misused.
  • Improve embryologist and clinician training in basic semen analysis.
  • Use DNA fragmentation testing selectively (e.g., in ICSI or repeated IVF failures).
  • Lab results must be interpreted with clinical context.
  • Inaccurate semen reports cause confusion, cost, and misdirection.
Dr. Poonam Nayar
  • Emotional needs of men often overlooked—focus remains on the woman.
  • Men experience shame, isolation, and relationship stress during fertility treatment.
  • Many men disengage after semen submission.
  • Involve men from the beginning of fertility counseling.
  • Normalize male emotional expression and offer couple-based therapy.
  • Shift from woman-centered to couple-centered communication.
  • Infertility affects relationships, not just individuals.
  • Addressing male emotions boosts treatment adherence and partnership strength.
All Panelists
  • Discussed male fertility stressors: obesity, trauma, alcohol, smoking, oxidative stress, infection.
  • Unregulated antioxidant use is widespread.
  • Personalize antioxidant therapy; avoid “one-size-fits-all” regimens.
  • Refer to trained andrologists (not general urologists) for complex male infertility.
  • Male fertility care must balance clinical and lifestyle inputs.
  • Polypharmacy without diagnostics is ineffective and wasteful.

Quotes from Panelists

Dr. Vasundara Jagannathan

"We need a standard questionnaire for semen analysis and must educate couples on proper collection techniques. Semen analysis is the most important test—train people to do it right."

Dr. Sutapa Samanta

"Oxidative stress is a known risk factor for abnormal sperm. Selective use of antioxidants like NAC, CoQ10, Vitamin C, E, zinc and omega-3 can improve IVF outcomes."

Vakil Jagveer Singh

"You're not just looking at sperm—you're analyzing a transport vehicle carrying critical information. Semen analysis is one of the most underlooked tests in India."

Dr. Poonam Nayar

"Men feel left out after semen submission. They think, ‘I’ve given her the doctor, the money—what more do you expect?’ This leads to emotional withdrawal and breakdown in communication."

Dr. Kaustubh Kulkarni (Moderator)

"Forty to fifty percent of infertility issues come from men—but for too long we’ve discussed male infertility without the male. It’s time we change that."

Panel 6: Fertility Inc.: India’s Next Healthcare Unicorn?

Distinguished Panel Members

Sukesh Chandra Gain

Senior Vice President & Head of Revenue and Operations, Birla Fertility & IVFi

Vinesh Gadhia

Executive Director & Chief Executive Officer, Ferty9 Fertility Center

Dr. Richa Jagtap

Medical Director – India & Consultant Reproductive Medicine, ART Fertility Clinics

Dr. Kshitiz Murdia

Whole-Time Director & Chief Executive Officer, Indira IVF

Bishwanath Ganguly

Chief Operating Officer, Nova IVF Fertility

Moderator: Madhur Singhal

Managing Partner, Healthcare and Lifesciences, Praxis Global Alliance

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Kshitiz Murdia
  • IVF is ideal for scalable, single-specialty growth due to emotional nature & need for personalization.
  • Success depends on unit economics, reproducible clinical outcomes, governance, and compliance.
  • Capital brings not just money, but pressure for ethics, cybersecurity, digitization.
  • Fix reproducibility of outcomes before scaling.
  • Treat governance, tech, team building, and compliance as a phased journey.
  • Don't do everything in Year 1.
  • Scale with discipline, not haste.
  • Clinical consistency is the foundation of brand trust and growth.
Dr. Richa Jagtap
  • Scaling must not dilute clinical integrity.
  • Focus should be on building a “long-running horse,” not a unicorn.
  • Sharing knowledge across teams enables better replication of outcomes.
  • Consolidate before replicating.
  • Strengthen training, knowledge transfer, and outcome consistency.
  • Clinical quality is the brand’s best growth strategy.
  • Culture of mentorship is key to national scale.
Sukesh Chandra Gain
  • Shared “4D Model”: Demand → Digital → Delivery → Dollar.
  • Scaling must be sequential, not simultaneous.
  • Governance and central clinical training are crucial.
  • Set infra, SOPs, training, and tracking systems before chasing investment.
  • Use centralized monitoring for consistency.
  • Build the clinical engine before fueling growth.
  • Scale comes from readiness, not just ambition.
Bishwanath Ganguly
  • IVF competition is intense; digital marketing costs are soaring (~30% YoY increase).
  • Success lies in patient experience—not just medical outcomes.
  • Need to move focus from IVF to overall fertility care.
  • Shift outreach from “lead generation” to top-of-the-funnel awareness.
  • Implement NPS, real-time feedback, and brand experience metrics.
  • Patients choose on experience, not just efficacy. Fertility literacy will drive long-term growth.
Vinesh Gadhia
  • Research and innovation are key differentiators.
  • India faces regulatory hurdles in research; global partnerships help bridge this.
  • IVF needs to mature from service delivery to scientific leadership.
  • Encourage India–global research collaboration.
  • Reduce red tape to support innovation in IVF tech.
  • Innovation fuel’s identity in a saturated market.
  • Science must lead strategy, not just scale.
Madhur Singhal
  • IVF must be viewed not just as clinical, but as retail + tech + consumer business.
  • Success comes from process, systems, and patient value—not founder personality.
  • Think scale only after achieving clinical and operational clarity.
  • Fundraising should be timed after proof of replicability.
  • India can produce global IVF unicorns—but only if fundamentals are strong and replicable.

Quotes from Panelists

Dr. Kshitiz Murdia

"Fix your outcomes first. Then scale. And don’t expect to get everything right on Day 1—it’s a journey."

Dr. Richa Jagtap

"As a clinician, I’m not chasing unicorns. I’m building strong, long-running horses that can deliver every day."

Sukesh Chandra Gain

"You need the four Ds: Demand, Digital, Delivery, and Dollar. Don’t touch the last until the first three are rock solid."

Bishwanath Ganguly

"Everyone’s chasing the patient at the bottom of the funnel. We need to start educating them at the top—before they even realize they need IVF."

Vinesh Gadhia

"India is great for IVF treatment but poor for research. Global collaboration is how we bridge that gap."

Madhur Singhal (Moderator)

"You’re delivering babies, yes. But you're also delivering returns, reliability, and retail discipline."

Fireside Chat: Pioneering Paths – Female Leaders in Fertility & the Future They’re Shaping

Distinguished Panel Members

Dr. Indira Hinduja

Padmashri Awardee

1st Lady Awardee by Ministry of Health & Family Welfare

Honorary Gynaecologist (IVF and Infertility Specialist), P.D. Hinduja Hospital & Medical Research Centre

Consultant, Obstetrics & Gynaecology, Jaslok Hospital & Breach Candy Hospital, Mumbai

Dr. Shweta Mittal Gupta (Moderator)

Secretary General, Indian Fertility Society (IFS)

Co-Director & Unit Head, Centre of IVF & Human Reproduction, Sir Ganga Ram Hospital, New Delhi

Key Panel Insights & Recommendations

Panelist
Key Statement(s) with Data
Recommendation(s)
Takeaway(s)
Dr. Indira Hinduja
  • Initially wanted to pursue pediatrics but shifted to OBGYN. Early exposure to neonatology inspired her path.
  • Developed IVF protocols from scratch in India; collected oocytes from sterilization patients.
  • Created India’s first GIFT baby and first donor oocyte IVF baby.
  • Achieved successful pregnancy on her 18th patient.
  • Built entire IVF setup herself without international training.
  • Uphold honesty and ethical transparency in practice.
  • Focus on self-reliance and scientific curiosity.
  • IVF professionals must engage in ongoing research beyond routine practice.
  • IVF is a gateway not just to conception, but to scientific discovery.
  • India's IVF future depends on investment in research and clinician-led innovation.
  • Female leadership must model integrity and resilience.
Dr. Shweta Mittal Gupta (Moderator)
  • Highlighted the critical role of mentorship in IVF.
  • Framed the discussion around legacy, ethics, and future potential of reproductive science.
  • Acknowledged Dr. Hinduja’s pioneering contributions to Indian fertility medicine.
  • Inspire next-gen clinicians through stories of resilience and integrity.
  • Facilitate knowledge transfer between generations of IVF professionals.
  • Legacy shapes culture; sharing experiences sustains progress.
  • Female role models in IVF redefine leadership and scientific responsibility.

Quotes from Panelists

Dr. Indira Hinduja

"I was never taught IVF. I never went abroad. Whatever I did, I did with my own hands—from preparing the media, washing glassware, to distilling water."

"The first successful pregnancy happened in the 18th patient. That’s why, even today, 18 is my lucky number."

"I don’t believe in fooling the patient. If there is a 10% chance, I say there is a 10% chance. I don't give false hope."

"I have always believed in telling the patient not to waste their money if there’s no hope. The patient’s well-being comes first."

"We talk of IVF only for infertility, but it can help in cancer treatment, genetic disease prevention, and regenerative medicine. It’s a goldmine for research."

Dr. Shweta Mittal Gupta (Moderator)

"You are the reason for many of us to pursue IVF. Your resilience and innovation created the foundation we now walk on."

"It is important for the next generation to hear your journey—not just the successes, but the struggles and the science behind them."

IVF EXCELLENCE AWARDS

Organisation Category

Award Category
Recipient
Outstanding Contribution to Women’s Hormonal Health & Wellness

The PCOS Society, India

Outstanding Patient Care in IVF - West

Yashoda Fertility & IVF Centre

Excellence in Reproductive Immunology

Revvity

Emerging Innovator in IVF Lab Infrastructure

Altus Airflow

Best Make in India Fertility Product Line

Shinelife Group

Best Innovation & Scientific Initiatives – Thymosin Alpha (Guficin Alpha)

Gufic Biosciences

Excellence in Nutritional Support for Assisted Reproduction

Meyer Vitabiotics

Fertility Champions of the Year

Samarth Life Sciences

Pioneer in Therapeutic Innovation in Indian IVF Ecosystem

Bharat Serums And Vaccines Limited

Best IVF/Fertility Chain of the Year

Seeds of Innocens I&M Clinic Pvt Ltd

Best IVF/Fertility Chain of the Year - North

Yellow Fertility & IVF Centre

Best IVF/Fertility Chain of the Year - South

Ferty9 Fertility Center

Most Innovative ART Center - Regional

Dream Flower IVF Centre

Best Tech Solutions for IVF Clinics & Labs

Ubq Technologies Pvt Ltd

Excellence in Standardization Practices for IVF Centres

Ferty9 Fertility Center

Excellence in Immunology-Driven Fertility Care

Dr. Raut's Centre for Reproductive Immunology

Standalone IVF Clinic of the Year - West

Xenith Advanced Fertility Centre, Candor IVF

Standalone IVF Clinic of the Year - South

Sri Chakra Fertility

Standalone IVF Clinic of the Year

Panacea Hospital & Laproscopy and IVF Centre

Emerging Standalone IVF Clinic of the Year - West

IVF ANGELS

Best IVF Lab Solutions Partner

Cooper Surgical

Medical Device of the Year for Fertility

Safe Scientific Inc

IVF Clinic with Outstanding Community Service

Shubham Hospitals and Test Tube Baby Centre

Outstanding Patient Care in IVF - North s

Simran IVF- Fertility & IVF Centres

Best Fertility Education Program

Kasturi ReproAssist Concepts

Fertility Hospital of the Year - West

Umadevi Sitaram Bairagi Hospital Fertility and Research Centre

Fertility Hospital of the Year - North

Yashoda Super Speciality Medicentre, Unit of Yashoda Super Speciality Hospital

Outstanding Patient Care in IVF - South

Bliss Fertility

Excellence in In-Hospital Fertility Care Services

Continental Fertility Centre

Outstanding Patient Care in IVF - West

Candor IVF

Individual Category

Award Category
Recipient
Excellence in Gyne-Endocrinology and Women’s Health

Dr. Suvarna Khadilkar

Educational Leadership in ART & Clinical Embryology

Dr. (Prof) Col. Pankaj Talwar, VSM

Center of Excellence in Advanced Reproductive Technologies

Dr. M. Gouri Devi

Institutional Excellence in Fertility Services

Dr. K D Nayar

Rising Voice in Reproductive Medicine

Dr. Navina Singh

Leadership in Minimally Invasive Reproductive Care

Dr. Kuldeep Jain

Pioneer in IVF & Embryology – National

Dr. Jatin Shah

Excellence in Clinical IVF Practice & Society Leadership

Dr. Shweta Mittal Gupta

Emerging IVF Leader – North India

Dr. Parul Agrawal

Excellence in Reproductive Medicine – North India

Dr. Anushka Madan

Excellence in Clinical IVF Practice - East

Dr. Saurav Prakash Maity

Excellence in Clinical IVF Practice - South

Dr. Phani Madhuri

Young Achiever in Fertility Care - West

Dr. Mohit Saraogi

Excellence in Reproductive Medicine – South India

Dr. R Aruna Ashok

Excellence in Clinical IVF Practice - North

Dr. Sonali Gupta

Best-in-Region IVF Excellence - East

Dr. Shashi Bala

Young Achiever in Fertility Care - East

Dr. Khushboo

Rising Star in IVF - West

Dr. Amiti Agrawal

Promising IVF Specialist – Maharashtra

Dr. Ketki Patil Mhaske

Excellence in Clinical IVF Practice - West

Dr. Mayuri More

Emerging IVF Specialist – East India

Dr. Sutapan Samanta

Outstanding Patient Care in IVF

Dr. Pratibha Baldhawa

Next-Gen Fertility Specialist

Dr. Dharam Shah

Rising Star in Fertility & Cosmetic Gynecology

Dr. Yuvrajsingh Jadeja

Laparoscopic Surgeon of the Year for IVF - Central India

Dr. Dhaval A. Baxi

Lifetime Excellence in Advancing Fertility Care in India

Dr. Kamini Rao

Lifetime Achievement in Pioneering IVF & Reproductive Science in India

Dr. Indira Hinduja

Healthcare Entrepreneur of the Year in Fertility Innovation

Dr. Kshitiz Murdia

Leadership in Fertility Counseling & Patient Wellness

Dr. Poonam Nayar

IVF Specialist of the Year - South

Dr. Jyothi Budi

Outstanding Contribution in Reproductive Medicine & OncoFertility

Dr. Rinoy Sreedharan

OB-GYN of the Year - South

Dr. Rajni Priyadarshini Bangari

Rising Star in OB-GYN - South

Dr. Sasi Priya Aravalli

Excellence in Leadership & Clinical Practice in IVF

Dr. Manisha Kundnani

Embryologist of the Year - National

Ajay Srivastava

Embryologist of the Year - South

Dr. Sindhuja Srinivasan

Embryologist of the Year - West

Dr. Kalyani Bade, Dr. Atita Shinde

Embryologist of the Year - East

Dr. Jugal Jyoti Borah, Dr. Dayanidhi Kumar

Emerging Embryologist of the Year - North

Dr. Sapna Tyagi

Rising Star in IVF - South

Dr. Vidyalatha Atluri, Dr. Swapna Yaramareddy

Rising Star in IVF - Central India

Dr. Anuradha Tibrewal

Emerging IVF Leader – West India

Dr. Rajendra Shitole

Women's Health Leader of the Year – National

Dr. Nandita Palshetkar

Trailblazer in Women’s Health & Fertility - National

Dr. Rishma Dhillon Pai

Champion for Women’s Health – Clinical & Policy Impact

Dr. Sunita Tandulwadkar

IVF Specialist of the Year - North

Dr. Richa Singh

Emerging IVF Specialist of the Year

Dr. Sarah Zaidi

IVF Specialist of the Year - West

Dr. Ramesh Gaikwad

Annexure

A. Summit Details

Date: 22nd June 2025
Venue: Courtyard by Marriott, Mumbai
Theme: Ethics | Access | Innovation
Partners: Voice of Healthcare (VOH), Indian Fertility Society (IFS)

B. Key Sessions

1
Women's Health in Transition
Ethics, empowerment, and early diagnostics
2
Laws of Life
ART Act, autonomy, and access
3
The Fertility Divide
Making IVF affordable and inclusive
4
Tomorrow's Baby
Technology, identity, and long-term ethical concerns
5
Male Fertility & Emotional Wellbeing
Addressing the unspoken journey
6
Fertility Inc.
Growth, governance, and India's IVF unicorns
7
Special Presentations
Digital transformation and prenatal screening
8
Fireside Chat
Female leadership in fertility: legacy and vision
9
IVF Excellence & Innovation Awards
Honoring pioneers and changemakers

C. Stakeholders Present

IVF specialists and embryologists
Clinical psychologists and technologists
Policymakers and legal experts
Healthcare entrepreneurs and investors
Representatives from fertility centers, pharma, and diagnostics

D. Output & Recommendations

Push for tiered ART access models and insurance inclusion
Implement standardized data reporting and national registries
Strengthen ART legal frameworks with inclusive, patient-centric guidelines
Encourage innovation that balances technology with ethics and equity
Promote fertility literacy and early hormonal health education
Recognize the need for psychological and emotional support in IVF journeys